Franklin Resources Inc Neogenomics Inc Transaction History

Franklin Resources Inc

$343 Billion
Q4 2024

A detailed history of Franklin Resources Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Franklin Resources Inc holds 1,461,406 shares of NEO stock, worth $16.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,461,406

Previous 2,043,840 28.5%

Holding current value

$16.2 Million

Previous $30.1 Million 20.11%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$13.0 - $18.43 $7.57 Million - $10.7 Million	-582,434 Reduced 28.5%	1,461,406 $24.1 Million
Q3 2024 Nov 12, 2024	BUY	$13.4 - $17.73 $532,516 - $704,590	39,740 Added 1.98%	2,043,840 $30.1 Million
Q2 2024 Aug 14, 2024	SELL	$13.01 - $15.77 $1.59 Million - $1.93 Million	-122,498 Reduced 5.76%	2,004,100 $27.8 Million
Q1 2024 May 13, 2024	BUY	$14.06 - $16.79 $9.22 Million - $11 Million	655,556 Added 44.56%	2,126,598 $33.4 Million
Q4 2023 Feb 09, 2024	SELL	$11.67 - $20.73 $33,306 - $59,163	-2,854 Reduced 0.19%	1,471,042 $23.8 Million
Q3 2023 Nov 13, 2023	BUY	$12.15 - $17.85 $12,150 - $17,850	1,000 Added 0.07%	1,473,896 $18.1 Million
Q2 2023 Aug 11, 2023	BUY	$14.1 - $19.83 $1.09 Million - $1.53 Million	77,310 Added 5.54%	1,472,896 $23.7 Million
Q1 2023 May 12, 2023	BUY	$9.09 - $19.45 $1,290 - $2,761	142 Added 0.01%	1,395,586 $24.3 Million
Q4 2022 Feb 10, 2023	SELL	$6.45 - $12.07 $39,712 - $74,314	-6,157 Reduced 0.44%	1,395,444 $12.9 Million
Q3 2022 Nov 14, 2022	BUY	$7.86 - $12.91 $140,253 - $230,366	17,844 Added 1.29%	1,401,601 $12.1 Million
Q2 2022 Aug 11, 2022	BUY	$7.06 - $13.97 $12,270 - $24,279	1,738 Added 0.13%	1,383,757 $11.3 Million
Q1 2022 May 13, 2022	BUY	$12.15 - $35.28 $2.89 Million - $8.38 Million	237,512 Added 20.75%	1,382,019 $16.8 Million
Q4 2021 Feb 11, 2022	SELL	$30.49 - $48.49 $304,351 - $484,027	-9,982 Reduced 0.86%	1,144,507 $39.1 Million
Q3 2021 Nov 12, 2021	BUY	$41.66 - $52.52 $147,184 - $185,553	3,533 Added 0.31%	1,154,489 $55.7 Million
Q2 2021 Aug 13, 2021	SELL	$36.62 - $51.69 $90,597 - $127,881	-2,474 Reduced 0.21%	1,150,956 $52 Million
Q1 2021 May 13, 2021	BUY	$41.56 - $59.88 $60,552 - $87,245	1,457 Added 0.13%	1,153,430 $55.6 Million
Q4 2020 Feb 10, 2021	BUY	$36.08 - $56.47 $21,648 - $33,882	600 Added 0.05%	1,151,973 $62 Million
Q3 2020 Nov 12, 2020	SELL	$33.26 - $40.48 $1.52 Million - $1.85 Million	-45,726 Reduced 3.82%	1,151,373 $42.5 Million
Q2 2020 Aug 13, 2020	SELL	$24.21 - $31.02 $250,985 - $321,584	-10,367 Reduced 0.86%	1,197,099 $44 Million
Q1 2020 May 13, 2020	SELL	$20.5 - $34.53 $1.25 Million - $2.1 Million	-60,812 Reduced 4.79%	1,207,466 $33.3 Million
Q4 2019 Feb 12, 2020	SELL	$18.96 - $29.84 $4.45 Million - $7 Million	-234,588 Reduced 15.61%	1,268,278 $37.1 Million
Q3 2019 Nov 14, 2019	BUY	$19.12 - $26.24 $89,175 - $122,383	4,664 Added 0.31%	1,502,866 $28.7 Million
Q2 2019 Aug 14, 2019	BUY	$19.57 - $24.1 $106,402 - $131,031	5,437 Added 0.36%	1,498,202 $32.9 Million
Q1 2019 May 14, 2019	SELL	$12.14 - $20.46 $12,637 - $21,298	-1,041 Reduced 0.07%	1,492,765 $30.5 Million
Q4 2018 Feb 12, 2019	SELL	$11.24 - $18.5 $23,682 - $38,979	-2,107 Reduced 0.14%	1,493,806 $18.8 Million
Q3 2018 Nov 13, 2018	BUY	$12.5 - $15.38 $8.44 Million - $10.4 Million	675,525 Added 82.34%	1,495,913 $23 Million
Q2 2018 Aug 14, 2018	SELL	$7.99 - $14.05 $5.89 Million - $10.4 Million	-737,005 Reduced 47.32%	820,388 $10.8 Million
Q1 2018 May 10, 2018	BUY	$7.23 - $8.76 $5.67 Million - $6.87 Million	784,493 Added 101.5%	1,557,393 $12.7 Million
Q4 2017 Feb 14, 2018	BUY	$8.02 - $11.18 $6.2 Million - $8.64 Million	772,900	772,900 $6.85 Million

Others Institutions Holding NEO

# of Institutions

282

Shares Held

124M

Call Options Held

751K

Put Options Held

107K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.4B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Neogenomics Inc Transaction History